Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/S0140-6736(21)00357-3 http://scihub22266oqcxt.onion/10.1016/S0140-6736(21)00357-3 33617776!7906642!33617776     free     free     free Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Lancet 2021 ; 397 (10277): 878 Nephropedia Template TP {{tp|p=33617776|t=2021. Rationale to continue approving placebo-controlled COVID-19 vaccine trials in LMICs |pdf=|usr=}}{{33617776}} gab.com Text Rationale to continue approving placebo-controlled COVID-19 vaccine trials in LMICs JO: Lancet http://www.kidney.de/pget.php?&tw=1&pmid=33617776 #FOAvip ä Twit Text FOAVip Rationale to continue approving placebo-controlled COVID-19 vaccine trials in LMICs ????Lancet http://www.kidney.de/pget.php?&tw=1&pmid=33617776 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33617776 #FOAvip English Wikipedia <ref>{{Cite pmid|33617776}}</ref> Rationale to continue approving placebo-controlled COVID-19 vaccine trials in LMICs #MMPMID33617776 Sisa I; Noblecilla E; Orozco F Lancet 2021[Mar]; 397 (10277): 878 PMID33617776show ga ä |*COVID-19 Vaccines/supply & distribution[MESH] |*Developing Countries[MESH] |COVID-19[MESH] |Humans[MESH] |Placebos[MESH] |Randomized Controlled Trials as Topic/economics/*ethics[MESH] |Risk Assessment[MESH] |SARS-CoV-2[MESH]Rationale to continue approving placebo-controlled COVID-19 vaccine tr(epmc).pdf DeepDyve Pubget Overpricing